Kevin Eggan, PhD

Kevin Eggan serves as Head of Research and Early Development at BioMarin Pharmaceutical Inc., where he leads the company’s discovery research programs. Prior to joining BioMarin, Kevin was a professor in the department of Stem Cell and Regenerative Biology at Harvard and Director of the Stem Cell program at the Broad Institute’s Stanley Center. He garnered international recognition for his seminal work in stem cell biology, receiving the MacArthur Foundation “Genius Grant” in 2006 and being selected as a Howard Hughes Medical Institute Early Career Scientist. One of his areas of expertise is in using stem cell technologies to better understand nervous system disorders such as amyotrophic lateral sclerosis (ALS) and schizophrenia toward the development of new therapeutics. Kevin received a B.S. from the University of Illinois and a Ph.D. from the Massachusetts Institute of Technology.